Chem-Bio Informatics Journal
Online ISSN : 1347-0442
Print ISSN : 1347-6297
ISSN-L : 1347-0442
Current issue
Displaying 1-3 of 3 articles from this issue
original
  • Kazushi Matsumura
    2025 Volume 25 Pages 1-18
    Published: January 31, 2025
    Released on J-STAGE: January 31, 2025
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    Relevant exposure routes need to be taken into account when performing chemical risk assessments for humans. Chemical risks are often assessed by performing route-to-route extrapolations based on oral repeated dose toxicity studies if route-specific toxicity data are unavailable. When performing a route-to-route extrapolation, an extrapolation factor derived from differences in absorption after exposure through different routes needs to be estimated. In this study, we used a machine learning (ML) and regression-based approach to estimate extrapolation-factor-like coefficients for oral-to-inhalation extrapolations using chemical structures and physicochemical properties. We used well-reviewed chemicals with human chronic toxicity values for specific administration routes (oral reference dose and inhalation reference concentration) available. ML regression models for predicting inhalation reference concentrations were developed using oral reference doses and molecular features as descriptors. The ML-based regression models gave better predictions than models using only molecular features or even single constant extrapolation factors, suggesting that the ML-based approach offers advantages over other oral-to-inhalation extrapolation methods.

  • Hosoya Ryuichiro, Ishii-Nozawa Reiko, Tomoko Terajima, Hajime Kagaya, ...
    2025 Volume 25 Pages 19-27
    Published: March 31, 2025
    Released on J-STAGE: March 31, 2025
    JOURNAL OPEN ACCESS FULL-TEXT HTML

    Medication-induced hiccups, although uncommon, can significantly reduce patients’ quality of life. We had previously identified nicotine as a potential trigger of drug-induced hiccups. However, the mechanisms and risk factors, particularly those related to the route of administration, remain unclear. This study used the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) to investigate nicotine-induced hiccups, particularly focusing on the routes of administration and patient factors. We analyzed 14,836,467 cases reported between January 1, 2004, and March 31, 2022, which were downloaded from the FDA website. Of the 198,556 adverse event reports for nicotine, 970 involved hiccups. We performed univariate analyses on routes of administration and drug formulations to determine their influence on the occurrence of hiccups. Furthermore, we analyzed patient information related to nicotine-induced hiccups. Men were more frequently affected by nicotine-induced hiccups than women, with a higher incidence in older patients. Oral nicotine administration via gum and lozenges was more significantly associated with the occurrence of hiccups than other routes. Nicotine-induced hiccups are influenced by the administration route, particularly oral formulations, such as gum and lozenges. These findings indicate the need for further studies to elucidate the mechanisms of nicotine-induced hiccups and to develop preventive strategies.

calculation report
  • Tsuyoshi Esaki, Hirofumi Watanabe, Yugo Shimizu, Reiko Watanabe, Yuki ...
    Article type: Calculation Report
    2025 Volume 25 Pages 28-35
    Published: May 15, 2025
    Released on J-STAGE: May 15, 2025
    JOURNAL OPEN ACCESS FULL-TEXT HTML
    Supplementary material

    The cost and time required for drug discovery have increased, prompting the need for more efficient methods to predict compound properties using artificial intelligence (AI). In particular, the prediction of absorption, distribution, metabolism, and excretion (ADME) properties is crucial. Intrinsic metabolic clearance (CLint) is an essential property in ADME because it affects the side effects or the dosage schedule. In silico machine learning (ML) models for estimating CLint have been developed, but due to the inherent complexity of AI techniques, it is difficult to obtain ideas for a more effective structure. Therefore, we employed SHAP (SHapley Additive exPlanations), an explainable AI (XAI) method, to elucidate the contributions of molecular substructures to CLint predictions. We constructed a random forest model, classified into low and high clearance categories. SHAP values were calculated to visualize the importance of features, and significant substructures influencing CLint were identified. The model demonstrated a high recall for predicting low-CLint compounds; however, its overall accuracy for high-CLint classification was low. This highlights its potential for filtering out low-CLint compounds rather than accurately identifying those with high-CLint. Visualization of SHAP values provided insights into substructure modifications to improve CLint, thus providing valuable guidance for drug optimization. This approach highlights the effectiveness of integrating explainable AI methods to improve the interpretability of ML models in drug discovery.

feedback
Top